Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Livmarli42.85M61.90%
Bile Acid Medicines26.07M37.66%
License and other revenue305K0.44%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States186.37M100.00%